March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Two City of Hope Researchers Honored by American Cancer Society
December 4, 2017 | Samantha Bonar
City of Hope’s Sunita Patel, Ph.D., and Mei Kong, Ph.D., were recently honored by the American Cancer Society with their Giants of Science Hope award at the Society’s annual gala in October.
City of Hope Researcher Receives Grant to Improve Cognitive Outcomes in Young Cancer Patients
July 7, 2017 | Samantha Bonar
Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects in childhood cancer survivors from bilingual and Spanish-speaking families.
Struggling with chemo brain? 7 tips that will help
February 3, 2016 | Nancy Brands Ward
As an editor for more than 20 years, Erin Michaela Sweeney was adept at helping people find the right words to express themselves. But after five rounds of chemotherapy, she found herself using the imprecise word “thingy” in sentences to refer to objects whose name she couldn’t remember.
Women's cancers: Support is vital in, and after, cancer treatment
March 16, 2014 | Elizabeth Stewart
In this series – this part focuses on the need for support during, and after, treatment – we explore crucial strides made against women's cancers by City of Hope researchers during the past year. The projects are many and varied, involving the basics of fighting cancer, analyses of who's at greatest risk, the search for surprising new therapies, the testing of new treatments, and the follow-up with survivors and their partners.
Tracking down a cancer-related bane of the brain
January 24, 2012 | City of Hope Staff
City of Hope’s Sunita Patel , Ph.D., is getting closer to tracking down the causes of cancer-related cognitive decline — or “ chemo brain ,” as patients call it — thanks to a grant from the American Cancer Society.